Skip to main content

LKFT · Lakefront Biotherapeutics NV · Share Buybacks

Track LKFT — free
$33.49 +0.10 (+0.30%) Play latest call Q1 2026 earnings call transcript
Market Cap
$2.20B
Shares
65.90M
Volume · Nov 20 38.91K Avg daily vol (3M) 281.53K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
50,000,000 EUR
as of 2026-11-11 · from Press release (reviewed)
Program Announced Authorized Remaining Runs Through
2026-11-11 50,000,000 EUR — —
Key facts CIK 1421876 CUSIP 36315X101 13F (30d) 109 filings 93 filers Visit website Investor relations